Volume Matters in Ultrasound-Guided Perineural Dextrose Injection for Carpal Tunnel Syndrome: A Randomized, Double-Blinded, Three-Arm Trial

Meng-Ting Lin, Chun-Li Liao, Ming-Yen Hsiao, Hsueh-Wen Hsueh, Chi-Chao Chao, Chueh-Hung Wu, Meng-Ting Lin, Chun-Li Liao, Ming-Yen Hsiao, Hsueh-Wen Hsueh, Chi-Chao Chao, Chueh-Hung Wu

Abstract

Ultrasound-guided perineural dextrose injection (PDI) has been reported effective for carpal tunnel syndrome (CTS). Higher volume of injectate may reduce adhesion of median nerve from other tissues, but volume-dependent effects of PDI in CTS remain unknown. We aimed to investigate whether PDI with different injectate volumes had different effects for CTS participants. In this randomized, double-blinded, three-arm trial, 63 wrists diagnosed with CTS were randomized into three groups that received ultrasound-guided PDI with either 1, 2 or 4 ml of 5% dextrose water. All participants finished this study. Primary outcome as visual analog scale (VAS) and secondary outcomes including Boston Carpal Tunnel Questionnaire (BCTQ), Disability of the Arm, Shoulder and Hand score (QuickDASH), electrophysiological studies and cross-sectional area (CSA) of the median nerve at carpal tunnel inlet were assessed before and after PDI at the 1st, 4th, 12th and 24th weeks. For within-group analysis, all three groups (21 participants, each) revealed significant improvement from baseline in VAS, BCTQ and QuickDASH at the 1st, 4th, 12th and 24th weeks. For between-group analysis, 4 ml-group yielded better VAS reduction at the 4th and 12th weeks as well as improvement of BCTQ and QuickDASH at the 1st, 4th, and 12th weeks, compared to other groups. No significant between-group differences were observed in electrophysiological studies or median nerve CSA at any follow-up time points. There were no severe complications in this trial, and transient minor adverse effects occurred equally in the three groups. In conclusion, ultrasound-guided PDI with 4 ml of 5% dextrose provided better efficacy than with 1 and 2 ml based on symptom relief and functional improvement for CTS at the 1st, 4th, and 12th week post-injection, with no reports of severe adverse effects. There was no significant difference between the three groups at the 24th-week post-injection follow-up. Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT03598322.

Keywords: dextrose; entrapment neuropathy; hydrodissection; injection; median nerve.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2020.625830/full#supplementary-material. Click here for additional data file.

Copyright © Lin, Liao, Hsiao, Hsueh, Chao and Wu.

Figures

FIGURE 1
FIGURE 1
Study flow diagram. D5W, 5% dextrose water.
FIGURE 2
FIGURE 2
Mean change from baseline between three groups at follow-up time points (1st, 4th, 12th and 24th week) in (A) visual analog scale (VAS), (B) Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) scores, (C) QuickDASH, and (D) cross-sectional area of median nerve (CSA). Asterisk represented significant difference between three groups.

References

    1. Alsaeid M. A. (2019). Dexamethasone versus hyaluronidase as an adjuvant to local anesthetics in the ultrasound-guided hydrodissection of the median nerve for the treatment of carpal tunnel syndrome patients. Anesth. Essays. Res. 13 (3), 417 10.4103/aer.AER_104_19
    1. Armstrong T., Devor W., Borschel L., Contreras R. (2004). Intracarpal steroid injection is safe and effective for short‐term management of carpal tunnel syndrome. Muscle Nerve 29 (1), 82–88. 10.1002/mus.10512
    1. Atroshi I., Flondell M., Hofer M., Ranstam J. (2013). Methylprednisolone injections for the carpal tunnel syndrome: a randomized, placebo-controlled trial. Ann. Intern. Med. 159 (5), 309–317. 10.7326/0003-4819-159-5-201309030-00004
    1. Atroshi I., Gummesson C., Johnsson R., Ornstein E., Ranstam J., Rosén I. (1999). Prevalence of carpal tunnel syndrome in a general population. JAMA 282 (2), 153–158. 10.1001/jama.282.2.153
    1. Beaton D. E., Wright J. G., Katz J. N., and Upper Extremity Collaborative Group (2005). Development of the QuickDASH: comparison of three item-reduction approaches. JBJS 87 (5), 1038–1046. 10.2106/00004623-200505000-00015
    1. Bertrand H., Kyriazis M., Reeves K. D., Lyftogt J., Rabago D. (2015). Topical mannitol reduces capsaicin-induced pain: results of a pilot-level, double-blind, randomized controlled trial. PM R 7 (11), 1111–1117. 10.1016/j.pmrj.2015.05.002
    1. Bland J. D. (2005). Carpal tunnel syndrome. Curr. Opin. Neurol. 18 (5), 581–585. 10.1097/01.wco.0000173142.58068.5a
    1. Bland J., Rudolfer S. (2003). Clinical surveillance of carpal tunnel syndrome in two areas of the United Kingdom, 1991–2001. J. Neurol. Neurosurg. Psychiatry 74 (12), 1674–1679. 10.1136/jnnp.74.12.1674
    1. Chang C.-W., Wang Y.-C., Chang K.-F. (2008). A practical electrophysiological guide for non-surgical and surgical treatment of carpal tunnel syndrome. J. Hand Surg. Eur. Vol. 33 (1), 32–37. 10.1177/1753193408087119
    1. Chen P.-C., Chuang C.-H., Tu Y.-K., Bai C.-H., Chen C.-F., Liaw M.-Y. (2015). A Bayesian network meta-analysis: comparing the clinical effectiveness of local corticosteroid injections using different treatment strategies for carpal tunnel syndrome. BMC Musculoskelet. Disord. 16 (1), 363 10.1186/s12891-015-0815-8
    1. Ellis R., Blyth R., Arnold N., Miner-Williams W. (2017). Is there a relationship between impaired median nerve excursion and carpal tunnel syndrome? A systematic review. J. Hand Ther. 30 (1), 3–12. 10.1016/j.jht.2016.09.002
    1. Ettema A. M., Amadio P. C., Zhao C., Wold L. E., An K.-N. (2004). A histological and immunohistochemical study of the subsynovial connective tissue in idiopathic carpal tunnel syndrome. JBJS 86 (7), 1458–1466. 10.2106/00004623-200407000-00014
    1. Evers S., Thoreson A. R., Smith J., Zhao C., Geske J. R., Amadio P. C. (2018). Ultrasound‐guided hydrodissection decreases gliding resistance of the median nerve within the carpal tunnel. Muscle Nerve 57 (1), 25–32. 10.1002/mus.25723
    1. Gottlieb N. L., Riskin W. G. (1980). Complications of local corticosteroid injections. JAMA 243 (15), 1547–1548. 10.1001/jama.1980.03300410035021
    1. Huisstede B. M., Friden J., Coert J. H., Hoogvliet P. (2014). Carpal tunnel syndrome: hand surgeons, hand therapists, and physical medicine and rehabilitation physicians agree on a multidisciplinary treatment guideline-results from the European HANDGUIDE Study. Arch. Phys. Med. Rehabil. 95 (12), 2253–2263. 10.1016/j.apmr.2014.06.022
    1. Kasten S. J., Louis D. S. (1996). Carpal tunnel syndrome: a case of median nerve injection injury and a safe and effective method for injecting the carpal tunnel. J. Fam. Pract. 43 (1), 79–83.
    1. LaBan M. M., Friedman N. A., Zemenick G. A. (1986). “Tethered” median nerve stress test in chronic carpal tunnel syndrome. Arch. Phys. Med. Rehabil. 67 (11), 803–804. 10.5555/uri:pii:0003999386901565
    1. Lee J. Y., Park Y., Park K. D., Lee J. K., Lim O. K. (2014). Effectiveness of ultrasound-guided carpal tunnel injection using in-plane ulnar approach: a prospective, randomized, single-blinded study. Medicine 93 (29), e350 10.1097/MD.0000000000000350
    1. Levine D. W., Simmons B. P., Koris M. J., Daltroy L. H., Hohl G. G., Fossel A. H., et al. (1993). A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. JBJS 75 (11), 1585–1592. 10.2106/00004623-199311000-00002
    1. Li T. Y., Chen S. R., Shen Y. P., Chang C. Y., Su Y. C., Chen L. C., et al. (2020). Long-term outcome after perineural injection with 5% dextrose for carpal tunnel syndrome: a retrospective follow-up study. Rheumatology (Oxford). keaa361 10.1093/rheumatology/keaa361
    1. Maniquis-Smigel L., Dean Reeves K., Jeffrey Rosen H. (2016). Short term analgesic effects of 5% dextrose epidural injections for chronic low back pain: a randomized controlled trial. Anesth. Pain. Med. 7 (1), e42550 10.5812/aapm.42550
    1. Page M. J., O’Connor D., Pitt V., Massy‐Westropp N. (2012). Exercise and mobilisation interventions for carpal tunnel syndrome. Cochrane Database Syst. Rev. CD009899 10.1002/14651858.CD009899
    1. Peters-Veluthamaningal C., Winters J. C., Groenier K. H., Meyboom-de Jong B. (2010). Randomised controlled trial of local corticosteroid injections for carpal tunnel syndrome in general practice. BMC Fam. Pract. 11 (1), 54 10.1186/1471-2296-11-54
    1. Roghani R. S., Holisaz M. T., Tarkashvand M., Delbari A., Gohari F., Boon A. J., et al. (2018). Different doses of steroid injection in elderly patients with carpal tunnel syndrome: a triple-blind, randomized, controlled trial. Clin. Interv. Aging 13, 117 10.2147/CIA.S151290
    1. Shen Y. P., Li T. Y., Chou Y. C., Ho T. Y., Ke M. J., Chen L. C., et al. (2019). Comparison of perineural platelet‐rich plasma and dextrose injections for moderate carpal tunnel syndrome: a prospective randomized, single‐blind, head‐to‐head comparative trial. J. Tissue Eng. Regen. Med. 13 (11), 2009–2017. 10.1002/term.2950
    1. Smith J., Wisniewski S. J., Finnoff J. T., Payne J. M. (2008). Sonographically guided carpal tunnel injections: the ulnar approach. J. Ultrasound. Med. 27 (10), 1485–1490. 10.7863/jum.2008.27.10.1485
    1. Tai T.-W., Wu C.-Y., Su F.-C., Chern T.-C., Jou I.-M. (2012). Ultrasonography for diagnosing carpal tunnel syndrome: a meta-analysis of diagnostic test accuracy. Ultrasound Med. Biol. 38 (7), 1121–1128. 10.1016/j.ultrasmedbio.2012.02.026
    1. Tat J., Wilson K. E., Keir P. J. (2015). Pathological changes in the subsynovial connective tissue increase with self-reported carpal tunnel syndrome symptoms. Clin. Biomech. 30 (4), 360–365. 10.1016/j.clinbiomech.2015.02.015
    1. Wang J. C., Lin K. P., Liao K. K., Chang Y. C., Wang K. A., Huang Y. F., et al. (2018). Sonographic median nerve change after steroid injection for carpal tunnel syndrome. Muscle Nerve 58 (3), 402–406. 10.1002/mus.26171
    1. Watabiki T., Kiso T., Kuramochi T., Yonezawa K., Tsuji N., Kohara A., et al. (2011). Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect. J. Pharmacol. Exp. Ther. 336 (3), 743–750. 10.1124/jpet.110.175570
    1. Wu Y. T., Chen S. R., Li T. Y., Ho T. Y., Shen Y. P., Tsai C. K., et al. (2019). Nerve hydrodissection for carpal tunnel syndrome: a prospective, randomized, double‐blind, controlled trial. Muscle Nerve 59 (2), 174–180. 10.1002/mus.26358
    1. Wu Y.-T., Ho T.-Y., Chou Y.-C., Ke M.-J., Li T.-Y., Huang G.-S., et al. (2017a). Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Sci. Rep. 7 (1), 94 10.1038/s41598-017-00224-6
    1. Wu Y.-T., Ho T.-Y., Chou Y.-C., Ke M.-J., Li T.-Y., Tsai C.-K., et al. (2017b). Six-month efficacy of perineural dextrose for carpal tunnel syndrome: a prospective, randomized, double-blind, controlled trial. Mayo Clin. Proc. 92 (8), 1179–1189. 10.1016/j.mayocp.2017.05.025
    1. Wu Y. T., Ke M. J., Ho T. Y., Li T. Y., Shen Y. P., Chen L. C. (2018). Randomized double‐blinded clinical trial of 5% dextrose versus triamcinolone injection for carpal tunnel syndrome patients. Ann. Neurol. 84 (4), 601–610. 10.1002/ana.25332

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren